Your browser doesn't support javascript.
loading
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime?
Vivancos, A; Élez, E; Salazar, R.
  • Vivancos A; Cancer Genomics Lab, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Élez E; Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; CIBERONC, Barcelona, Spain; Universitat Autònoma de Barcelona (UAM), Barcelona, Spain.
  • Salazar R; CIBERONC, Barcelona, Spain; Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain; Oncobell, IDIBELL, Barcelona, Spain; Universitat de Barcelona (UB), L'Hospitalet, Barcelona, Spain. Electronic address: ramonsalazar@iconcologia.net.
Ann Oncol ; 29(3): 532-534, 2018 03 01.
Article en En | MEDLINE | ID: mdl-29401228
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Quimioradioterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Quimioradioterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article